Relationship between sleep-related impairment and cognitive functioning among breast cancer survivors

Abstract Purpose Sleep-related impairment and cancer-related cognitive decline (CRCD) are common, disruptive symptoms affecting breast cancer survivors. This study examined the association between sleep-related impairment and both self-reported and objective cognitive functioning in breast cancer survivors following treatment. Methods Participants ( N = 253) from the I Can! Improving Cognition After Cancer study completed the NIH Toolbox Digit Symbol test to measure Processing Speed and a battery of neurocognitive tests of Memory, Executive Functioning, and Attention domains. Self-reported cognition was assessed with the PROMIS Cognitive Function and Abilities scales. Sleep-related impairment was measured by the PROMIS Sleep-Related Impairment scale. Multiple linear regression models were used to examine the associations between sleep-related impairment and the six cognitive outcomes, adjusting for demographic and cancer treatment factors. Results Participants were on average 59 (SD = 8.9) years old, majority identified as White (77%) and were college graduates (42%). Fifty-seven percent of participants underwent chemotherapy, 80% received hormone therapy, and 81% were treated with radiation. Greater sleep-related impairment was significantly associated with worse executive function ( β = −0.01, 95% CI: −0.022, −0.000, p = 0.04), worse cognitive abilities ( β = −0.28, 95% CI: −0.375, −0.184, p < 0.001), and worse cognitive function ( β = −0.25, 95% CI: −0.323, −0.167, p < 0.001). No significant associations were observed for memory, attention, or processing Speed. Conclusion Greater sleep-related impairment was associated with poorer self-reported cognitive functioning and modest differences in executive functioning among breast cancer survivors, underscoring the importance of addressing sleep-related impairment in this population. Implications for Cancer Survivors Assessing sleep-related impairment during survivorship care may help identify survivors experiencing cognitive difficulties and related daytime functional concerns.

Authors

Institutions

Publication Details

Journal
Journal of Cancer Survivorship
Published
2026-06-13
DOI
https://doi.org/10.1007/s11764-026-02057-7
Primary Topic
Cancer-related cognitive impairment studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relationship between sleep-related impairment and cognitive functioning among breast cancer survivors

Victoria M. Telles, Marisa Torres-Ruiz, Sheri J. Hartman, Victoria Mac et al.
Journal of Cancer Survivorship
Cancer-related cognitive impairment studies
article

Relationship between sleep-related impairment and cognitive functioning among breast cancer survivors

Victoria M. Telles, Marisa Torres-Ruiz, Sheri J. Hartman, Victoria Mac, Rowena Tam
article en

Abstract

Abstract Purpose Sleep-related impairment and cancer-related cognitive decline (CRCD) are common, disruptive symptoms affecting breast cancer survivors. This study examined the association between sleep-related impairment and both self-reported and objective cognitive functioning in breast cancer survivors following treatment. Methods Participants ( N = 253) from the I Can! Improving Cognition After Cancer study completed the NIH Toolbox Digit Symbol test to measure Processing Speed and a battery of neurocognitive tests of Memory, Executive Functioning, and Attention domains. Self-reported cognition was assessed with the PROMIS Cognitive Function and Abilities scales. Sleep-related impairment was measured by the PROMIS Sleep-Related Impairment scale. Multiple linear regression models were used to examine the associations between sleep-related impairment and the six cognitive outcomes, adjusting for demographic and cancer treatment factors. Results Participants were on average 59 (SD = 8.9) years old, majority identified as White (77%) and were college graduates (42%). Fifty-seven percent of participants underwent chemotherapy, 80% received hormone therapy, and 81% were treated with radiation. Greater sleep-related impairment was significantly associated with worse executive function ( β = −0.01, 95% CI: −0.022, −0.000, p = 0.04), worse cognitive abilities ( β = −0.28, 95% CI: −0.375, −0.184, p < 0.001), and worse cognitive function ( β = −0.25, 95% CI: −0.323, −0.167, p < 0.001). No significant associations were observed for memory, attention, or processing Speed. Conclusion Greater sleep-related impairment was associated with poorer self-reported cognitive functioning and modest differences in executive functioning among breast cancer survivors, underscoring the importance of addressing sleep-related impairment in this population. Implications for Cancer Survivors Assessing sleep-related impairment during survivorship care may help identify survivors experiencing cognitive difficulties and related daytime functional concerns.

Journal of Cancer Survivorship
San Diego State University (US), University of California San Diego (US), Human Longevity (United States) (US)
No poverty
Openalex Percentile: Top 6%
Cancer-related cognitive impairment studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.